Intrinsic Value of S&P & Nasdaq Contact Us

Alphatec Holdings, Inc. ATEC NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
54/100
4/7 Pass
SharesGrow Intrinsic Value
$162.02
+1306.4%
Analyst Price Target
$23.33
+102.5%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Alphatec Holdings, Inc. (ATEC) has a negative trailing P/E of -11.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 42.7 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -8.53%, forward earnings yield 2.34%. PEG 0.76 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.76); analyst target implies upside (+102.5%).
  • Forward P/E 42.7 — analysts expect a return to profitability with estimated EPS of $0.27 for FY2026.
  • PEG Ratio 0.76 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -8.53% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 2.34% as earnings recover.
  • Analyst consensus target $23.33 (+102.5% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 54/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
54/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
MOAT
70/100
→ Income
GROWTH
73/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — ATEC

Valuation Multiples
P/E (TTM)-11.7
Forward P/E42.7
PEG Ratio0.76
Forward PEG0.76
P/B Ratio46.64
P/S Ratio2.22
EV/EBITDA-49.0
Per Share Data
EPS (TTM)$-0.96
Forward EPS (Est.)$0.27
Book Value / Share$0.24
Revenue / Share$5.09
FCF / Share$0.02
Yields & Fair Value
Earnings Yield-8.53%
Forward Earnings Yield2.34%
Dividend Yield0.00%
SharesGrow IV$162.02 (+1306.4%)
Analyst Target$23.33 (+102.5%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -0.9 0.01 -0.66 0.23 -
2017 -14.8 0.16 -1.28 0.33 -
2018 -2.8 -0.01 4.60 0.88 -
2019 -6.5 -0.20 5.13 3.27 -
2020 -12.3 -1.49 6.18 6.72 -
2021 -7.7 -0.28 13.84 4.52 -
2022 -8.4 4.22 -36.83 3.64 -
2023 -9.8 -2.06 18.01 3.80 -
2024 -8.1 0.30 139.10 2.15 -
2025 -22.0 1.46 87.63 4.13 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-3.53 $120.25M $-30.32M -25.2%
2017 $-0.17 $101.74M $-2.29M -2.3%
2018 $-0.82 $91.69M $-28.98M -31.6%
2019 $-1.09 $113.43M $-56.9M -50.2%
2020 $-1.18 $144.86M $-78.99M -54.5%
2021 $-1.50 $243.21M $-144.33M -59.3%
2022 $-1.47 $350.87M $-152.15M -43.4%
2023 $-1.54 $482.26M $-186.64M -38.7%
2024 $-1.13 $611.56M $-162.12M -26.5%
2025 $-0.96 $764.16M $-143.36M -18.8%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.27 $-0.03 – $0.48 $891.53M $888.48M – $897.99M 5
2027 $0.55 $0.52 – $0.58 $1.04B $1.01B – $1.08B 5
2028 $0.84 $-0.03 – $1.71 $1.19B $1.18B – $1.19B 2
2029 $1.20 $1.17 – $1.25 $1.37B $1.35B – $1.42B 1
2030 $1.59 $1.55 – $1.66 $1.55B $1.52B – $1.6B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message